Photo by impulsq from unsplash
Many patients with anti-GABABR encephalitis respond to immunotherapy, emphasizing the importance of early diagnosis. Van Coevorden-Hameete et al. show that while the majority of patients have epilepsy, others present with… Click to show full abstract
Many patients with anti-GABABR encephalitis respond to immunotherapy, emphasizing the importance of early diagnosis. Van Coevorden-Hameete et al. show that while the majority of patients have epilepsy, others present with progressive dementia without seizures. Adding KCTD16, an auxiliary protein, to a GABABR cell-based assay improves sensitivity without loss of specificity.
Keywords:
gababr encephalitis;
clinical spectrum;
expanded clinical;
anti gababr
Journal Title: Brain
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!